394 related articles for article (PubMed ID: 23317816)
1. Role of macrophage polarization in tumor angiogenesis and vessel normalization: implications for new anticancer therapies.
Chen P; Bonaldo P
Int Rev Cell Mol Biol; 2013; 301():1-35. PubMed ID: 23317816
[TBL] [Abstract][Full Text] [Related]
2. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.
Rolny C; Mazzone M; Tugues S; Laoui D; Johansson I; Coulon C; Squadrito ML; Segura I; Li X; Knevels E; Costa S; Vinckier S; Dresselaer T; Åkerud P; De Mol M; Salomäki H; Phillipson M; Wyns S; Larsson E; Buysschaert I; Botling J; Himmelreich U; Van Ginderachter JA; De Palma M; Dewerchin M; Claesson-Welsh L; Carmeliet P
Cancer Cell; 2011 Jan; 19(1):31-44. PubMed ID: 21215706
[TBL] [Abstract][Full Text] [Related]
3. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
Leite de Oliveira R; Hamm A; Mazzone M
Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
[TBL] [Abstract][Full Text] [Related]
4. Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer.
Maione F; Giraudo E
Methods Mol Biol; 2015; 1267():349-65. PubMed ID: 25636478
[TBL] [Abstract][Full Text] [Related]
5. Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications.
De Bock K; Cauwenberghs S; Carmeliet P
Curr Opin Genet Dev; 2011 Feb; 21(1):73-9. PubMed ID: 21106363
[TBL] [Abstract][Full Text] [Related]
6. Intermedin: a novel regulator for vascular remodeling and tumor vessel normalization by regulating vascular endothelial-cadherin and extracellular signal-regulated kinase.
Zhang W; Wang LJ; Xiao F; Wei Y; Ke W; Xin HB
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2721-32. PubMed ID: 22922959
[TBL] [Abstract][Full Text] [Related]
7. M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.
Jarosz-Biej M; Kamińska N; Matuszczak S; Cichoń T; Pamuła-Piłat J; Czapla J; Smolarczyk R; Skwarzyńska D; Kulik K; Szala S
PLoS One; 2018; 13(1):e0191012. PubMed ID: 29320562
[TBL] [Abstract][Full Text] [Related]
8. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
[TBL] [Abstract][Full Text] [Related]
9. Diverse macrophages polarization in tumor microenvironment.
Rhee I
Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
[TBL] [Abstract][Full Text] [Related]
10. Optical imaging and tumor angiogenesis.
Lin PC
J Cell Biochem; 2003 Oct; 90(3):484-91. PubMed ID: 14523982
[TBL] [Abstract][Full Text] [Related]
11. Normalization of the vasculature for treatment of cancer and other diseases.
Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
[TBL] [Abstract][Full Text] [Related]
12. Vascular targeting therapy: potential benefit depends on tumor and host related effects.
Horsman MR; Bohn AB; Busk M
Exp Oncol; 2010 Sep; 32(3):143-8. PubMed ID: 21403608
[TBL] [Abstract][Full Text] [Related]
13. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
Viallard C; Larrivée B
Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of tumor endothelial cells and drug delivery.
Hida K; Maishi N; Sakurai Y; Hida Y; Harashima H
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):140-147. PubMed ID: 26626622
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation.
Collet G; Skrzypek K; Grillon C; Matejuk A; El Hafni-Rahbi B; Lamerant-Fayel N; Kieda C
Vascul Pharmacol; 2012; 56(5-6):252-61. PubMed ID: 22446152
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications.
Lin Y; Xu J; Lan H
J Hematol Oncol; 2019 Jul; 12(1):76. PubMed ID: 31300030
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated macrophages: role in cancer development and therapeutic implications.
Salmaninejad A; Valilou SF; Soltani A; Ahmadi S; Abarghan YJ; Rosengren RJ; Sahebkar A
Cell Oncol (Dordr); 2019 Oct; 42(5):591-608. PubMed ID: 31144271
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress, polarization of macrophages and tumour angiogenesis: Efficacy of caffeic acid.
Oršolić N; Kunštić M; Kukolj M; Gračan R; Nemrava J
Chem Biol Interact; 2016 Aug; 256():111-24. PubMed ID: 27378625
[TBL] [Abstract][Full Text] [Related]
20. Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis.
Lin Y; Wei C; Liu Y; Qiu Y; Liu C; Guo F
Cancer Sci; 2013 Sep; 104(9):1217-25. PubMed ID: 23691974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
